Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis
about
High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unFractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.
P2860
Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Higher Stem Cell Dose Infusion ...... ltiple Myeloma and Amyloidosis
@ast
Higher Stem Cell Dose Infusion ...... ltiple Myeloma and Amyloidosis
@en
type
label
Higher Stem Cell Dose Infusion ...... ltiple Myeloma and Amyloidosis
@ast
Higher Stem Cell Dose Infusion ...... ltiple Myeloma and Amyloidosis
@en
prefLabel
Higher Stem Cell Dose Infusion ...... ltiple Myeloma and Amyloidosis
@ast
Higher Stem Cell Dose Infusion ...... ltiple Myeloma and Amyloidosis
@en
P2093
P2860
P1476
Higher Stem Cell Dose Infusion ...... ltiple Myeloma and Amyloidosis
@en
P2093
Charles S Cleeland
James M Reuben
Loretta A Williams
Muzaffar H Qazilbash
Qaiser Bashir
Qiuling Shi
Richard E Champlin
Sergio A Giralt
Tito R Mendoza
P2860
P304
P356
10.1016/J.BBMT.2015.07.036
P577
2015-08-04T00:00:00Z